Matthew 7:25 Inc dba Thrive Pharmacy

FDA Regulatory Profile

Matthew 7:25 Inc dba Thrive Pharmacy appears in FDA public data with 3 recalls, 0 510(k) clearances, 2 FDA inspections, and 1 compliance action on record. Its most recent recall (D-1054-2020, Class II) was initiated on March 10, 2020.

Summary

Total Recalls
3
510(k) Clearances
0
Inspections
2
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-1054-2020Class IIBuprenorphine Black Cherry 2 mg Troche, supplied in plastic troche molds with cardboard outer sleeveMarch 10, 2020
D-1052-2020Class IIBuprexone Banana cream 6-0.6 mg Troche, supplied in plastic troche molds with cardboard outer sleeveMarch 10, 2020
D-1053-2020Class IIBuprenorphine Watermelon 8 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, March 10, 2020